SGShimon Glick

Shimon Glick

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shimon Glick has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

    • 29 September 2022
      • Vol. 95  (3) , 355-358
    Open Access

    The Emotions in Bioethical Decision-making

    by Shimon M. Glick

    In an era of evidence-based medicine and an increasing use of technology the question is raised again as to what extent emotions should play in medical and ethical decision-making. While clearly the correct facts in each case are a sine qua non for ethical decision-making, and one should evaluate each situation rationally in accord with accepted ethical principles, the appropriate role of the emotions in decisionmaking is gaining increased attention in part as a result of newer research in neuroethics. In end-of-life care there often exists a disconnect between the "rational" analysis by many philosophers and ethicists and the emotional reactions of many physicians and nurses with respect to the comparison between withholding and withdrawal of life-sustaining therapy. It is suggested that these attitudes of many health care workers should not be ignored because they represent a critical, almost universal, and laudable value of reluctance to take human life, a value so strongly ingrained in the ethos of the medical profession.


  • We Reject the “Equivalence Thesis”

    by Shimon Glick, Alan Jotkowitz

    (2019). We Reject the “‘‘Equivalence Thesis”. The American Journal of Bioethics: Vol. 19, No. 3, pp. 53-54.


  • Commentary on ‘Wearing humanism on your sleeve’

    by Shimon M Glick

    I was deeply moved and inspired by Jason Dubroff’s article1 objecting to the source of the white coat distributed to the entering medical students at his school. The article stimulated me to ponder its implications and led to some thoughtful discussions with colleagues. Here was a busy medical student who was appropriately disturbed at what he regarded as a kind of ethical failure at the very ceremony, which was meant to exemplify and emphasise the values of humanism. However, unlike many of us who notice evidence of ethical insensitivity, react with a sigh or a comment, and go on with our lives without significant alteration in our normal activities, Jason initiated an investigation of the issue, researched it in his own time, and even proposed remedial actions—a remarkable, unusual and impressive course of events. His article reinforced some of my personal prejudices. To those of my colleagues who nostalgically bewail the alleged decrease in idealism in today’s entering medical students, I can point to Jason as an example of the kind of ethical sensitivity, …

  • The medical education system in Israel

    by Shmuel Reis, Shimon M Glick, Jacob Urkin, Peter Gilbey


  • Open Access

    Policy issues related to educating the future Israeli medical workforce: an international perspective

    by Stephen C. Schoenbaum, Peter Crome, Raymond H. Curry, Elliot S. Gershon, Shimon M. Glick, David R. Katz, Ora Paltiel, Jo Shapiro

    A 2014 external review of medical schools in Israel identified several issues of importance to the nation’s health. This paper focuses on three inter-related policy-relevant topics: planning the physician and healthcare workforce to meet the needs of Israel’s population in the 21st century; enhancing the coordination and efficiency of medical education across the continuum of education and training; and the financing of medical education. All three involve both education and health care delivery. The physician workforce is aging and will need to be replenished. Several physician specialties have been in short supply, and some are being addressed through incentive programs. Israel’s needs for primary care clinicians are increasing due to growth and aging of the population and to the increasing prevalence of chronic conditions at all ages. Attention to the structure and content of both undergraduate and graduate medical education and to aligning incentives will be required to address current and projected workforce shortage areas. Effective workforce planning depends upon data that can inform the development of appropriate policies and on recognition of the time lag between developing such policies and seeing the results of their implementation. The preclinical and clinical phases of Israeli undergraduate medical education (medical school), the mandatory rotating internship (stáge), and graduate medical education (residency) are conducted as separate “silos” and not well coordinated. The content of basic science education should be relevant to clinical medicine and research. It should stimulate inquiry, scholarship, and lifelong learning. Clinical exposures should begin early and be as hands-on as possible. Medical students and residents should acquire specific competencies. With an increasing shift of medical care from hospitals to ambulatory settings, development of ambulatory teachers and learning environments is increasingly important. Objectives such as these will require development of new policies. Undergraduate medical education (UME) in Israel is financed primarily through universities, and they receive funds through VATAT, an education-related entity. The integration of basic science and clinical education, development of earlier, more hands-on clinical experiences, and increased ambulatory and community-based medical education will demand new funding and operating partnerships between the universities and the health care delivery system. Additional financing policies will be needed to ensure the appropriate infrastructure and support for both educators and learners. If Israel develops collaborations between various government agencies such as the Ministries of Education, Health, and Finance, the universities, hospitals, and the sick funds (HMOs), it should be able to address successfully the challenges of the 21st century for the health professions and meet its population’s needs.


  • Maimonides Reincarnated

    by Shimon M. Glick, Alan B. Jotkowitz

    The writings of Maimonides, the 12th-century physician, Talmudic and philosophic scholar, are remarkably relevant for modern medicine. Whereas the specific medical recommendations are obviously outdated, Maimonides' perceptive insights into professional responsibilities and medical ethics remain as useful guides even in our postmodern era.


    • 1 March 2013
      • Vol. 152  (3) , 129-31, 184

    [Circumcision in male newborns--update].

    by Shimon M Glick

    Recently, there have been efforts in a number of countries to forbid the circumcision of infants and children. This position, which is based on alleged violation of autonomy and on serious harm to the infant or child, is not supported by the medical literature. Controlled studies have accumulated showing the major health benefits of circumcision of infants; there is a decrease in urinary tract infections, a virtual elimination of cancer of the penis, a reduction in HIV and HPV infections, as well as other sexually transmitted diseases, and perhaps, reductions in prostatic cancer and in uterine cervical cancer. The complications of the procedure are minimal, especially when performed in infancy. Recent studies have not confirmed the alleged reduction in sexual pleasure as a result of circumcision. Therefore, there is no justification, whatsoever, for attempts to forbid circumcision of infants. On the contrary, there seem to be good reasons to encourage such practices.

    • 1 September 2012
      • Vol. 14  (9) , 535-7

    Quo vadis, bioethics.

    by Shimon M Glick, Alan B Jotkowitz

    The recent paper by Giubilini and Minerva suggesting the ethical permissibility of infanticide of normal newborns, calling it "postbirth abortion," represents a dangerous deterioration of generally accepted ethical norms. Their proposal represents a clear example of the so-called slippery slope and we caution against abandoning the age-old traditions of the medical profession assigning intrinsic value to human life from birth. This article discusses the proposed concept, makes comparisons with earlier similar trends of thought, and highlights the dangers of the proposal.

    • 1 September 2012
      • Vol. 151  (9) , 537-40, 555

    [Telling the truth to Alzheimer and dementia patients in the early stages of the disease].

    by Sara Ilan, Shimon Glick, Alan Bruce Jotkowitz

    Disclosing the diagnosis of Alzheimer's disease to the patient is emotionally difficult and ethically challenging. Arguments against telling the truth include: diagnostic uncertainty, patient's inability to understand the diagnosis, patient's unwillingness to recognize the diagnosis, potential negative social implications, unpredictable emotional reactions and losing hope. Arguments in favor of truth telling include: patient autonomy, relations with the physician based on trust, emotional adaptation, future planning and support for the patients and their family. Current research in Western countries indicates that most patients of all ages wish to know their diagnosis, whereas many relatives and physicians believe that they should conceal it from the patient. Many physicians experience difficulties in delivering the diagnosis to the patient. Studies show that less than half of them reveal the diagnosis to the patient and rarely discuss the prognosis, even though they convey this information to the relatives. Patients' reactions to the diagnosis of Alzheimer's disease is influenced by the way it is delivered, the patients' emotional vulnerability, coping style and past experience with dementia. Reactions vary from denial, anger, fear, sorrow and depression to positive coping. The proper question is how to disclose the diagnosis and not whether it should be told. Disclosing the diagnosis is a complicated and dynamic process that should begin when there is suspicion of a cognitive decline. It demands physician sensitivity flexibility and discretion. Discussing the diagnosis in time enables the patient to be involved in treatment decisions and planning his or her future.

  • Synthetic Biology: A Jewish View

    by Shimon Glick

    The discipline of synthetic biology may be one of the most dramatic advances of the past few decades. It represents a radical upgrading of humankind's ability to manipulate the world in which we live. The potential for benefits to society is enormous, but the risks for deliberate abuse or dangerous miscalculations are no less great. There are serious ethical issues, legitimate concerns for biosafety, and fears of bioterrorism. The ethical dilemmas posed are new and challenging and are being addressed by various groups and commissions. The present paper presents a Jewish approach to some of the ethical issues posed by this new technology. Judaism traditionally looks favorably on man as a co-creator with God and encourages research for the benefit of humankind. Thus it would have a positive attitude towards the current goals of synthetic biology. But in the Jewish tradition man is also charged with stewardship over nature and is admonished to preserve and nurture, not just to exploit and destroy. In line with the Presidential Commission on Bioethics, it would support a carefully weighed balance between the precautionary and the "proactionary" approaches.